690 results on '"Weber, Sharon M."'
Search Results
2. ASO Visual Abstract: Association of Neighborhood Disadvantage with Short- and Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma
3. Impact of Preoperative Jaundice and Biliary Drainage on Short- and Long-term Outcomes among Patients with Gallbladder Cancer
4. Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma
5. Rethinking Routine Intensive Care After Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy: The Fiscal Argument
6. Incidence of Second Primary Melanoma in Cutaneous Melanoma Survivors
7. Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy
8. Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis
9. Promoting patient engagement during care transitions after surgery using mobile technology: Lessons learned from the MobiMD pilot study
10. Dynamic Prediction of Survival after Curative Resection of Gastric Adenocarcinoma: A landmarking-based analysis
11. Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer
12. Does the Volume-Outcome Association in Pancreas Cancer Surgery Justify Regionalization of Care? A Review of Current Controversies
13. Surgical Strategies for Bismuth Type I and II Hilar Cholangiocarcinoma: Impact on Long-Term Outcomes
14. Clinical and Cost Profile of Controlled Grade B Postoperative Pancreatic Fistula: Rationale for Their Consideration as Low Risk
15. ASO Visual Abstract: Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma
16. ASO Visual Abstract: Rethinking Routine Intensive Care After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: The Fiscal Argument
17. A telephone-based surgical transitional care program with improved patient satisfaction scores and fiscal neutrality
18. ASO Visual Abstract: Incidence of Second Primary Melanoma in Survivors of Cutaneous Melanoma
19. Emerging pathways for precision medicine in management of cholangiocarcinoma
20. Summary perioperative risk metrics within the electronic medical record predict patient-level cost variation in pancreaticoduodenectomy
21. Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database
22. What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?
23. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review
24. Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience
25. National Trends in Centralization of Surgical Care and Multimodality Therapy for Pancreatic Adenocarcinoma
26. Current Advances in Minimally Invasive Surgical Management of Perihilar Cholangiocarcinoma
27. ASO Author Reflections: Understanding the Broader Implications of the Volume–Outcome Impact on Pancreas Cancer Surgery
28. Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium
29. Analysis of 90-day cost for open versus minimally invasive distal pancreatectomy
30. Adaptation and Implementation of a Transitional Care Protocol for Patients Undergoing Complex Abdominal Surgery
31. ASO Visual Abstract: Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer
32. Neoadjuvant SBRT plus regional nodal irradiation with concurrent capecitabine for patients with resectable pancreatic cancer: Survival analysis of prospective phase 1 trial.
33. Editorial About: “A Prospective, Open-Label, Multicenter Phase II Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma”
34. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium
35. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium
36. Clinicopathologic score predicting lymph node metastasis in T1 gastric cancer
37. Feasibility of an Image-Based Mobile Health Protocol for Postoperative Wound Monitoring
38. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group
39. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium
40. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors
41. Natural History and Treatment Trends in Pancreatic Cancer Subtypes
42. Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma
43. Current Approaches in the Management of Hepatic Adenomas
44. Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium
45. ASO Visual Abstract: Does the Volume-Outcome Association in Pancreas Cancer Justify Regionalization of Care? A Review of Current Controversies
46. Improving Patient-Centered Transitional Care after Complex Abdominal Surgery
47. Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases
48. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy
49. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium
50. All-payer Spending on Common Hospital-based Services in California
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.